Latest News by Industry
DUBLIN--(BUSINESS WIRE)--Sep 20, 2022--
The "Nuclear Imaging Agents Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030" report has been added to ResearchAndMarkets.com's offering.
Nuclear Imaging Agents Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030 is built to visualize quantitative market trends within Diagnostic Imaging therapeutic area.
The model discusses in detail the impact of COVID-19 on Nuclear Imaging Agents market for the year 2020 and beyond. Nuclear Imaging is a noninvasive medical technique which uses radioactive tracers (generally F-18 Fluorodeoxyglucose) to assess and diagnose bodily functions and diseases. The diseases include cancers, cardiac diseases, gastrointestinal, endocrine and neurological diseases.
Nuclear Imaging Agent's have been classified into Positron Emission Tomography (PET) Systems and Single Photon Emission Computed Tomography (SPECT) Systems. The advanced version of these systems include PET/CT, PET/MRI, SPECT/CT and SPECT/MRI. These systems contain features of both PET and CT/MRI and SPECT and CT/MRI.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Currently marketed Nuclear Imaging Agents and evolving competitive landscape:
Global, Regional and Country level market specific insights:
Scope
Reasons to Buy
Companies Mentioned
For more information about this report visit https://www.researchandmarkets.com/r/crfr0k
View source version on businesswire.com:https://www.businesswire.com/news/home/20220920006095/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: HEALTH OTHER HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 09/20/2022 12:39 PM/DISC: 09/20/2022 12:39 PM
http://www.businesswire.com/news/home/20220920006095/en